Prospective Trial for the Implementation of Genetic Risk for Colorectal Cancer Screening

Endeavor Health1 个研究点分布在 1 个国家目标入组 100 人开始时间: 2026年6月1日最近更新: 2026年6月2日

适应症

试验速览

阶段: 不适用
状态: Enrolling By Invitation
发起方
入组人数: 100
试验地点: 1

研究概览研究设计入排标准研究者研究点记录与标识符相似试验

研究概览

简要总结

The goal of this study is to investigate genetic risk for colorectal cancer utilizing polygenic risk scores (PRS) for adults over 45 who have not received their first colonoscopy. The main questions it hopes to address are:

How does knowledge of a patient's genetic risk for colorectal cancer affect the uptake of initial screening colonoscopies?
How do colonoscopy outcomes compare between genetic risk groups?

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Prospective

入排标准

年龄范围: 45 Years 至 75 Years（Adult, Older Adult）
性别: All
接受健康志愿者: 是

入选标准

•- Due for initial screening colonoscopy per current guidelines

排除标准

•Prior colonoscopy
•Prior personal history of colorectal cancer or inflammatory bowel disease
•Medical contraindications to colonoscopy/sedation

研究者

发起方

Endeavor Health

申办方类型

Other

责任方

Principal Investigator

主要研究者

Jianfeng Xu

Vice President and Director, Genomic Translational Research

Endeavor Health

研究点 (1)

Loading locations...

相似试验

招募中

不适用

High-Risk Transcriptome Molecular Prediction Study of MASH-Associated Colorectal Polyps

NCT07463287Shanghai East Hospital100

进行中（未招募）

3 期

A study to evaluate the efficacy, safety and immunogenicity of Bevacizumab in metastatic colorectal cancer patients.

CTRI/2024/04/066032CuraTeQ Biologics Private Ltd168

尚未招募

不适用

Colorectal Adenoma CohortColorectal Neoplasms

NCT07523035Second Affiliated Hospital, School of Medicine, Zhejiang University1,280

招募中

不适用

Colorectal Lesion Evaluation and Appropriate Resolution (CLEAR) Study

NCT07479381Harbinger Health1,450

招募中

不适用

The Use of Artificial Intelligence for the Prediction of Recurrence After Resection of Colorectal Liver Metastases

NCT07385521Francesco De Cobelli1,000